102 related articles for article (PubMed ID: 14960318)
1. Involvement of the cGMP signalling pathway in the regulation of viability in insulin-secreting BRIN-BD11 cells.
Kaminski A; Gao H; Morgan NG
FEBS Lett; 2004 Feb; 559(1-3):118-24. PubMed ID: 14960318
[TBL] [Abstract][Full Text] [Related]
2. Expression and functional roles of guanylate cyclase isoforms in BRIN-BD11 β-cells.
Russell MA; Morgan NG
Islets; 2010; 2(6):374-82. PubMed ID: 21099339
[TBL] [Abstract][Full Text] [Related]
3. Biotin increases glucokinase expression via soluble guanylate cyclase/protein kinase G, adenosine triphosphate production and autocrine action of insulin in pancreatic rat islets.
Vilches-Flores A; Tovar AR; Marin-Hernandez A; Rojas-Ochoa A; Fernandez-Mejia C
J Nutr Biochem; 2010 Jul; 21(7):606-12. PubMed ID: 19560332
[TBL] [Abstract][Full Text] [Related]
4. Essential roles of the nitric oxide (no)/cGMP/protein kinase G type-Iα (PKG-Iα) signaling pathway and the atrial natriuretic peptide (ANP)/cGMP/PKG-Iα autocrine loop in promoting proliferation and cell survival of OP9 bone marrow stromal cells.
Wong JC; Fiscus RR
J Cell Biochem; 2011 Mar; 112(3):829-39. PubMed ID: 21328456
[TBL] [Abstract][Full Text] [Related]
5. Guanylyl cyclase inhibitors NS2028 and ODQ and protein kinase G (PKG) inhibitor KT5823 trigger apoptotic DNA fragmentation in immortalized uterine epithelial cells: anti-apoptotic effects of basal cGMP/PKG.
Chan SL; Fiscus RR
Mol Hum Reprod; 2003 Dec; 9(12):775-83. PubMed ID: 14614039
[TBL] [Abstract][Full Text] [Related]
6. Renal interstitial guanosine cyclic 3', 5'-monophosphate mediates pressure-natriuresis via protein kinase G.
Jin XH; McGrath HE; Gildea JJ; Siragy HM; Felder RA; Carey RM
Hypertension; 2004 May; 43(5):1133-9. PubMed ID: 15007031
[TBL] [Abstract][Full Text] [Related]
7. Cyclic GMP induced apoptosis via protein kinase G in oestrogen receptor-positive and -negative breast cancer cell lines.
Fallahian F; Karami-Tehrani F; Salami S; Aghaei M
FEBS J; 2011 Sep; 278(18):3360-9. PubMed ID: 21777390
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of cGMP-dependent protein kinase by the cell-permeable peptide DT-2 reveals a novel mechanism of vasoregulation.
Taylor MS; Okwuchukwuasanya C; Nickl CK; Tegge W; Brayden JE; Dostmann WR
Mol Pharmacol; 2004 May; 65(5):1111-9. PubMed ID: 15102939
[TBL] [Abstract][Full Text] [Related]
9. The bradykinin-cGMP-PKG pathway augments insulin sensitivity via upregulation of MAPK phosphatase-5 and inhibition of JNK.
Frigolet ME; Thomas G; Beard K; Lu H; Liu L; Fantus IG
Am J Physiol Endocrinol Metab; 2017 Sep; 313(3):E321-E334. PubMed ID: 28679626
[TBL] [Abstract][Full Text] [Related]
10. Effect of four cGMP analogues with different mechanisms of action on hormone release by porcine ovarian granulosa cells in vitro.
Sirotkin AV; Makarevich AV; Genieser HG; Kotwica J; Hetényi L
Exp Clin Endocrinol Diabetes; 2000; 108(3):214-9. PubMed ID: 10926319
[TBL] [Abstract][Full Text] [Related]
11. Cyclic GMP and protein kinase-G in myocardial ischaemia-reperfusion: opportunities and obstacles for survival signaling.
Burley DS; Ferdinandy P; Baxter GF
Br J Pharmacol; 2007 Nov; 152(6):855-69. PubMed ID: 17700722
[TBL] [Abstract][Full Text] [Related]
12. Regulation of spontaneous contractile activity in the bovine epididymal duct by cyclic guanosine 5'-monophosphate-dependent pathways.
Mewe M; Bauer CK; Müller D; Middendorff R
Endocrinology; 2006 Apr; 147(4):2051-62. PubMed ID: 16439452
[TBL] [Abstract][Full Text] [Related]
13. The role of the cyclic GMP-inhibited cyclic AMP-specific phosphodiesterase (PDE3) in regulating clonal BRIN-BD11 insulin secreting cell survival.
Ahmad M; Flatt PR; Furman BL; Pyne NJ
Cell Signal; 2000 Aug; 12(8):541-8. PubMed ID: 11027947
[TBL] [Abstract][Full Text] [Related]
14. Activation of protein kinase G up-regulates expression of 15-lipoxygenase-1 in human colon cancer cells.
Deguchi A; Xing SW; Shureiqi I; Yang P; Newman RA; Lippman SM; Feinmark SJ; Oehlen B; Weinstein IB
Cancer Res; 2005 Sep; 65(18):8442-7. PubMed ID: 16166323
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of active shuttle avoidance response by the NO-cGMP-PKG activator YC-1.
Chien WL; Liang KC; Fu WM
Eur J Pharmacol; 2008 Aug; 590(1-3):233-40. PubMed ID: 18590724
[TBL] [Abstract][Full Text] [Related]
16. Expression and functional activity of PPARgamma in pancreatic beta cells.
Welters HJ; McBain SC; Tadayyon M; Scarpello JH; Smith SA; Morgan NG
Br J Pharmacol; 2004 Aug; 142(7):1162-70. PubMed ID: 15237101
[TBL] [Abstract][Full Text] [Related]
17. Intrathecally administered cGMP-dependent protein kinase Ialpha inhibitor significantly reduced the threshold for isoflurane anesthesia: implication for a novel role of cGMP-dependent protein kinase Ialpha.
Tao YX; Hassan A; Johns RA
Anesthesiology; 2000 Feb; 92(2):493-9. PubMed ID: 10691237
[TBL] [Abstract][Full Text] [Related]
18. Effects of the imidazoline binding site ligands, idazoxan and efaroxan, on the viability of insulin-secreting BRIN-BD11 cells.
Gao H; Mourtada M; Morgan NG
JOP; 2003 May; 4(3):117-24. PubMed ID: 12743417
[TBL] [Abstract][Full Text] [Related]
19. Expression and function of cGMP-dependent protein kinase type I during medaka fish embryogenesis.
Yamamoto T; Suzuki N
J Biol Chem; 2005 Apr; 280(17):16979-86. PubMed ID: 15710621
[TBL] [Abstract][Full Text] [Related]
20. The NO signaling pathway differentially regulates KCC3a and KCC3b mRNA expression.
Di Fulvio M; Lauf PK; Adragna NC
Nitric Oxide; 2003 Nov; 9(3):165-71. PubMed ID: 14732340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
